MARKET

BJDX

BJDX

Bluejay Diagnostics Inc
NASDAQ
0.9213
-0.0287
-3.02%
After Hours: 0.9900 +0.0687 +7.46% 19:21 09/25 EDT
OPEN
0.9505
PREV CLOSE
0.9500
HIGH
0.9600
LOW
0.9100
VOLUME
286.41K
TURNOVER
--
52 WEEK HIGH
16.68
52 WEEK LOW
0.8002
MARKET CAP
4.12M
P/E (TTM)
-0.0186
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BJDX last week (0914-0918)?
Weekly Report · 6d ago
Weekly Report: what happened at BJDX last week (0907-0911)?
Weekly Report · 09/14 09:56
Weekly Buzz: JNJ Wins FDA Nod; AXGN, HCWB Strike Deals; ROIV, AZN, GPCR Lead Clinical Trials
NASDAQ · 09/11 16:06
Bluejay Diagnostics expands federal access via Lovell partnership
TipRanks · 09/08 21:19
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 09/08 17:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 09/08 12:05
Bluejay Diagnostics, Lovell Team Up To Access U.S. Federal Healthcare Market
NASDAQ · 09/08 10:58
Bluejay Diagnostics and Lovell Government partner to access federal healthcare
TipRanks · 09/08 10:35
More
About BJDX
Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes in critical care settings. It develops rapid tests using whole blood on its Symphony technology platform (Symphony), which consists of an analyzer and single-use protein detection cartridges that have the function of automatic stepwise feeding of reagent. The Symphony device is designed to produce laboratory-quality results in 20 minutes in critical care settings, including Intensive Care Units (ICUs) and Emergency Rooms (ERs). Its product candidate, the Symphony IL-6 test, is an immunoassay for the measurement of interleukin-6 (IL-6) to be used for the monitoring of disease progression in critical care settings. It is focused on pursuing the Symphony IL-6 test in the context of sepsis. IL-6 is a clinically established inflammatory biomarker, and is considered a 'first-responder', for the assessment of severity of infection and inflammation across many disease indications, including sepsis.

Webull offers Bluejay Diagnostics Inc stock information, including NASDAQ: BJDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BJDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BJDX stock methods without spending real money on the virtual paper trading platform.